NasdaqCM - Delayed Quote USD

Cassava Sciences, Inc. (SAVA)

2.2400
+0.1700
+(8.21%)
At close: May 20 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
146,930
142,278
107,333
81,482
32,868
Operating Income
-146,930
-142,278
-107,333
-81,482
-32,868
Net Non Operating Interest Income Expense
7,999
8,510
7,833
2,777
49
Other Income Expense
66,144
109,427
2,283
2,459
434
Pretax Income
-72,788
-24,342
-97,217
-76,246
-32,385
Net Income Common Stockholders
-72,788
-24,342
-97,217
-76,246
-32,385
Average Dilution Earnings
-1
-43,793
0
0
--
Diluted NI Available to Com Stockholders
-72,789
-68,135
-97,217
-76,246
-32,385
Basic EPS
-1.59
-0.53
-2.32
-1.90
-0.82
Diluted EPS
-1.59
-1.46
-2.32
-1.90
-0.82
Basic Average Shares
47,644.2500
46,329
41,932
40,202
39,405
Diluted Average Shares
47,644.2500
46,604
41,932
40,202
39,405
Total Operating Income as Reported
-146,098
-141,446
-105,957
-80,020
-32,868
Total Expenses
146,930
142,278
107,333
81,482
32,868
Net Income from Continuing & Discontinued Operation
-72,788
-24,342
-97,217
-76,246
-32,385
Normalized Income
-137,930
-132,525
-97,217
-76,246
-32,385
Interest Income
7,999
8,510
7,833
2,777
49
Net Interest Income
7,999
8,510
7,833
2,777
49
EBIT
-146,930
-142,278
-107,333
-81,482
-32,868
EBITDA
-145,889
-141,146
-105,803
-80,181
-32,334
Reconciled Depreciation
1,041
1,132
1,530
1,301
534
Net Income from Continuing Operation Net Minority Interest
-72,788
-24,342
-97,217
-76,246
-32,385
Total Unusual Items Excluding Goodwill
65,142
108,183
--
0
0
Total Unusual Items
65,142
108,183
--
0
0
Normalized EBITDA
-211,031
-249,329
-105,803
-80,181
-32,334
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 7/14/2000

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CABA Cabaletta Bio, Inc.
1.8800
-2.08%
 
AVXL Anavex Life Sciences Corp.
7.53
-10.78%
 
EYEN Eyenovia, Inc.
1.6700
+47.79%
 
ANVS Annovis Bio, Inc.
2.1400
+0.94%
 
AFMD Affimed N.V.
0.1815
0.00%
 
BLUE bluebird bio, Inc.
4.9800
0.00%
 
TNXP Tonix Pharmaceuticals Holding Corp.
29.90
+12.41%
 
NVAX Novavax, Inc.
7.68
-0.78%
 
PTIX Protagenic Therapeutics, Inc.
6.88
-38.02%
 
NCNA NuCana plc
0.0464
-3.73%